DK1032414T3 - Kombination af inhibitor for angiotensinomdannende enzym med et diuretikum til behandling af forstyrrelser i mikrokredsløbet - Google Patents

Kombination af inhibitor for angiotensinomdannende enzym med et diuretikum til behandling af forstyrrelser i mikrokredsløbet

Info

Publication number
DK1032414T3
DK1032414T3 DK98913813T DK98913813T DK1032414T3 DK 1032414 T3 DK1032414 T3 DK 1032414T3 DK 98913813 T DK98913813 T DK 98913813T DK 98913813 T DK98913813 T DK 98913813T DK 1032414 T3 DK1032414 T3 DK 1032414T3
Authority
DK
Denmark
Prior art keywords
diuretic
treatment
combination
converting enzyme
enzyme inhibitor
Prior art date
Application number
DK98913813T
Other languages
English (en)
Inventor
David Guez
Pierre Schiavi
Bernard Levy
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1032414T3 publication Critical patent/DK1032414T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98913813T 1997-11-19 1998-03-03 Kombination af inhibitor for angiotensinomdannende enzym med et diuretikum til behandling af forstyrrelser i mikrokredsløbet DK1032414T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714485A FR2771010B1 (fr) 1997-11-19 1997-11-19 Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
PCT/FR1998/000411 WO1999025374A1 (fr) 1997-11-19 1998-03-03 Combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires

Publications (1)

Publication Number Publication Date
DK1032414T3 true DK1032414T3 (da) 2003-09-01

Family

ID=9513523

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98913813T DK1032414T3 (da) 1997-11-19 1998-03-03 Kombination af inhibitor for angiotensinomdannende enzym med et diuretikum til behandling af forstyrrelser i mikrokredsløbet

Country Status (20)

Country Link
US (1) US6653336B1 (da)
EP (1) EP1032414B1 (da)
JP (1) JP2001523646A (da)
CN (1) CN1227029C (da)
AT (1) ATE239500T1 (da)
AU (1) AU740748B2 (da)
BR (1) BR9814885A (da)
CA (1) CA2310136C (da)
DE (1) DE69814444T2 (da)
DK (1) DK1032414T3 (da)
EA (1) EA002968B1 (da)
ES (1) ES2198708T3 (da)
FR (1) FR2771010B1 (da)
HU (1) HU226022B1 (da)
NO (1) NO20002479L (da)
NZ (1) NZ504220A (da)
PL (1) PL340561A1 (da)
PT (1) PT1032414E (da)
WO (1) WO1999025374A1 (da)
ZA (1) ZA986673B (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
CA2448997A1 (en) * 2001-05-31 2002-12-05 Microdose Technologies, Inc. Metering and packaging of controlled release medication
US20040156903A1 (en) * 2002-05-22 2004-08-12 Abrams Andrew L.. Metering and packaging of controlled release medication
FR2841140B1 (fr) * 2002-06-24 2004-10-01 Servier Lab Microcapsules pour la liberation retardee et controlee du perindopril
SI21507A (sl) * 2003-05-16 2004-12-31 LEK farmacevtska dru�ba d.d. Postopek za pripravo spojin z ace inhibitornim delovanjem
GB2423927A (en) * 2003-08-29 2006-09-13 Cotherix Inc Combination Of Cicletanine And An Oral Antidiabetic And/Or Blood Lipid-Lowering Agent For Treating Diabetes And Metabolic Syndrome
CN1292747C (zh) * 2003-09-16 2007-01-03 广东省心血管病研究所 一种用于治疗高血压的复方制剂
HRP20161602T1 (hr) * 2004-03-29 2016-12-30 Les Laboratoires Servier Postupak priprave čvrstog farmaceutskog pripravka
DE102004019845A1 (de) * 2004-03-29 2005-10-20 Krka Tovarna Zdravil D D Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
DE102004062257A1 (de) * 2004-12-23 2006-07-06 Merckle Gmbh Direkt verpresste Indapamid-Tabletten mit verzögerter Wirkstofffreisetzung
MY138209A (en) * 2005-03-11 2009-05-29 Servier Lab New (y) crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it.
BRPI0615607A2 (pt) * 2005-08-30 2011-05-24 Lek Pharmaceuticals composição farmacêutica compreendendo perindopril ou seus sais
DE102005058166A1 (de) * 2005-12-05 2007-06-06 Hexal Ag Matrixkontrolliertes transdermales System mit Amin-Salzen der ACE-Hemmer-Dicarbonsäuren
WO2008068577A2 (en) * 2006-12-01 2008-06-12 Glenmark Pharmaceuticals Limited Pharmaceutical compositions
SI22543A (sl) 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove soli perindoprila
CN106913860A (zh) 2011-09-29 2017-07-04 梅约医学教育与研究基金会 芳族阳离子肽和使用它们的方法
RU2618471C2 (ru) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение
EP3919052A4 (en) * 2019-01-09 2022-10-05 Fuso Pharmaceutical Industries, Ltd. Pharmaceutical composition for intraocular or oral administration for treatment of retinal diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK9200258U4 (da) * 1992-03-11 1993-07-23 Merck & Co Inc Farmaceutisk præparat indeholdende enalapril til brug mod hypertension
WO1996028185A2 (en) * 1995-03-16 1996-09-19 Pfizer Inc. Composition containing amlodipine, or a salt, or felodipine and an ace inhibitor

Also Published As

Publication number Publication date
CN1279615A (zh) 2001-01-10
WO1999025374A1 (fr) 1999-05-27
HUP0004544A3 (en) 2001-07-30
PL340561A1 (en) 2001-02-12
EA002968B1 (ru) 2002-12-26
ES2198708T3 (es) 2004-02-01
ZA986673B (en) 1999-02-04
HK1033096A1 (en) 2001-08-17
HUP0004544A2 (hu) 2001-06-28
FR2771010B1 (fr) 2003-08-15
EA200000536A1 (ru) 2000-10-30
EP1032414B1 (fr) 2003-05-07
DE69814444T2 (de) 2004-03-18
CA2310136C (fr) 2004-04-20
AU740748B2 (en) 2001-11-15
US6653336B1 (en) 2003-11-25
NO20002479D0 (no) 2000-05-12
CA2310136A1 (fr) 1999-05-27
CN1227029C (zh) 2005-11-16
HU226022B1 (en) 2008-03-28
JP2001523646A (ja) 2001-11-27
NO20002479L (no) 2000-05-12
FR2771010A1 (fr) 1999-05-21
BR9814885A (pt) 2000-10-03
DE69814444D1 (de) 2003-06-12
EP1032414A1 (fr) 2000-09-06
NZ504220A (en) 2003-05-30
AU6837798A (en) 1999-06-07
PT1032414E (pt) 2003-08-29
ATE239500T1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
DK1032414T3 (da) Kombination af inhibitor for angiotensinomdannende enzym med et diuretikum til behandling af forstyrrelser i mikrokredsløbet
TR200103216T2 (tr) Pirimidinon bileşimleri
EA200000768A1 (ru) ЗАМЕЩЕННЫЕ ОКСОАЗАГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ ФАКТОРА Ха
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
DE69528528D1 (de) Thrombin-inhibitoren
DE69840603D1 (de) Alpha-ketoamidhaltige multikatalytische protease inhibitoren
EA199900837A1 (ru) Способ применения ингибиторов циклооксигеназы-2 для предупреждения сердечно-сосудистых расстройств
DK0764167T3 (da) Bicyclisk lactamhæmmer af interleukin-1-beta-omdannende enzym
AU6870098A (en) Indazoles of cyclic ureas useful as hiv protease inhibitors
NO955074D0 (no) 1-substituerte istain- og oksindolderivater som inhibitorer til acetylkolinesterase
DE69904804D1 (de) Glucocorticoid selektive entzündungshemmende mittel
DK1053240T3 (da) Glucocorticoid-selektiv antiinflammatoriske midler
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
ATE234091T1 (de) Thrombin inhibitoren
BG99177A (bg) Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза
ATE335485T1 (de) Quinolin-enthaltende alpha-ketoamid-basierte inhibitoren von cystein- und serin protease
EP0975353A4 (en) PEPTIDYL-2-AMINO-1HYDROXYALKANESULPHONIC ACIDS AS CYSTEIN PROTEASE INHIBITORS
DE69836678D1 (de) Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf)
BR9809848A (pt) Composição
NO20003758L (no) Trekonserveringsmidler
BG100248A (bg) Инхибитори на скваленсинтетаза
DE69625230D1 (de) Thrombininhibitoren
NO20001548D0 (no) Endotelinantagonist og en renin-angiotensinsystem inhibitor som et kombinert preparat
TR199800847A3 (tr) Bir anjiyotensin dönüstürücü enzim inhibitörünün sabit doz bilesimi.
DE59808166D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure als mukolytikum